Literature DB >> 23535820

Peripheral arterial disease in patients with Behçet's disease.

Ilknur Balta1, Sevket Balta, Sait Demirkol, Ozlem Ekiz.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23535820     DOI： 10.1007/s00296-013-2729-9

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


× No keyword cloud information.
  10 in total

1.  Levels of circulating intercellular adhesion molecule-1 in patients with Behçet's disease.

Authors:  Kenan Saglam; M Ilker Yilmaz; Ayse Saglam; Mete Ulgey; Fatih Bulucu; Yavuz Baykal
Journal:  Rheumatol Int       Date:  2002-01       Impact factor: 2.631

2.  Behçet's disease: successful treatment with infliximab in 7 patients with severe vascular manifestations. A retrospective analysis.

Authors:  Sabine Adler; Iris Baumgartner; Peter M Villiger
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-04       Impact factor: 4.794

3.  Assessment of aortic stiffness and ventricular diastolic functions in patients with Behçet's disease.

Authors:  S Ercan Tunc; Abdullah Dogan; Omer Gedikli; Cagatay Arslan; Mehmet Sahin
Journal:  Rheumatol Int       Date:  2005-02-23       Impact factor: 2.631

4.  Behçet's disease in Brazilian patients: demographic and clinical features.

Authors:  Zoraida Sachetto; Nazira Mahayri; Rosemeire Holanda Ferraz; Lilian Teresa Lavras Costallat; Manoel Barros Bertolo
Journal:  Rheumatol Int       Date:  2011-04-11       Impact factor: 2.631

5.  Peripheral arterial involvement in Behcet's disease: an analysis of the results from a Korean referral center.

Authors:  Shin-Seok Yang; Keun-Myoung Park; Yang Jin Park; Young-Wook Kim; Young Soo Do; Hong Suk Park; Kwang Bo Park; Dong-Ik Kim
Journal:  Rheumatol Int       Date:  2013-02-16       Impact factor: 2.631

6.  Risk modification in patients with peripheral arterial disease: a retrospective survey.

Authors:  Fahed Youssef; Prakash Gupta; Dimitri P Mikhailidis; George Hamilton
Journal:  Angiology       Date:  2005 May-Jun       Impact factor: 3.619

7.  Short-term lipid-lowering treatment with atorvastatin improves renal function but not renal blood flow indices in patients with peripheral arterial disease.

Authors:  M E Alnaeb; F Youssef; D P Mikhailidis; G Hamilton
Journal:  Angiology       Date:  2006 Jan-Feb       Impact factor: 3.619

8.  Pattern and outcome of vascular involvement of Omani patients with Behcet's disease.

Authors:  Juma K Alkaabi; Anil Pathare
Journal:  Rheumatol Int       Date:  2010-02-04       Impact factor: 2.631

9.  Efficacy of etanercept in the treatment of a patient with Behçet's disease.

Authors:  Valentina Curigliano; Maria Giovinale; Claudia Fonnesu; Claudia Cerquaglia; Elena Verrecchia; Simona Turco; Chiara Manganelli; Raffaele Manna
Journal:  Clin Rheumatol       Date:  2008-03-11       Impact factor: 2.980

10.  Cytokine inhibitors: soluble tumor necrosis factor receptor 1 and interleukin-1 receptor antagonist in Behçet's disease.

Authors:  Nurşen Düzgün; Ergin Ayaşlioğlu; Hüseyin Tutkak; Olcay T Aydintuğ
Journal:  Rheumatol Int       Date:  2003-11-05       Impact factor: 2.631
  10 in total
  1 in total

1.  Correlation of clinical signs and symptoms of Behçet's disease with mean platelet volume (MPV) and red cell distribution width (RDW).

Authors:  Maryam Masoumi; Soraya Shadmanfar; Fereydoun Davatchi; Farhad Shahram; Massoomeh Akhlagi; Tahereh Faezi; Hoda Kavosi; Soroush Moradi; Javad Balasi
Journal:  Orphanet J Rare Dis       Date:  2020-10-21       Impact factor: 4.123
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.